LivaNova

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LivaNova and other ETFs, options, and stocks.

About LIVN

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). 

CEO
Vladimir A. Makatsaria
CEOVladimir A. Makatsaria
Employees
3,300
Employees3,300
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
1987
Founded1987
Employees
3,300
Employees3,300

LIVN Key Statistics

Market cap
4.44B
Market cap4.44B
Price-Earnings ratio
23.92
Price-Earnings ratio23.92
Dividend yield
—
Dividend yield—
Average volume
552.25K
Average volume552.25K
High today
—
High today—
Low today
—
Low today—
Open price
$80.90
Open price$80.90
Volume
0.00
Volume0.00
52 Week high
$85.76
52 Week high$85.76
52 Week low
$48.82
52 Week low$48.82

Stock Snapshot

As of today, LivaNova(LIVN) shares are valued at $80.62. The company's market cap stands at 4.44B, with a P/E ratio of 23.92.

During the trading day, LivaNova(LIVN) stock saw an opening price of $80.90, a peak of —, and a bottom of —.

Trading volume for LivaNova(LIVN) stock has reached 0, versus its average volume of 552.25K.

Over the past 52 weeks, LivaNova(LIVN) stock has traded between a high of $85.76 and a low of $48.82.

Over the past 52 weeks, LivaNova(LIVN) stock has traded between a high of $85.76 and a low of $48.82.

LIVN News

Simply Wall St 2d
What Is Drawing Fresh Attention To LivaNova? - Simply Wall Street

...

What Is Drawing Fresh Attention To LivaNova? - Simply Wall Street
Simply Wall St 3d
CORE VNS Results Could Be A Turning Point For LivaNova Stock

LivaNova reported that a peer-reviewed journal published 36-month CORE-VNS data showing clinically meaningful long-term effectiveness and safety for its VNS The...

TipRanks 4d
LivaNova announces Neuromodulation published 36-month results from CORE-VNS

LivaNova (LIVN) announced that the journal Neuromodulation: Technology at the Neural Interface has published the full 36-month results from the CORE-VNS study,...

Analyst ratings

75%

of 12 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own LIVN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.